Stock OGN ORGANON & CO.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Organon & Co.

Equities

OGN

US68622V1061

Market Closed - Nyse
Other stock markets
 04:00:02 2024-04-26 pm EDT 		5-day change 1st Jan Change
18.55 USD +0.71% Intraday chart for Organon & Co. +4.10% +28.64%
Apr. 09 Morgan Stanley Lifts Price Target on Organon to $18 From $17, Keeps Equalweight Rating MT
Apr. 08 Shanghai Henlius Biotech Denosumab Biosimilar HLX14 Meets Endpoint MT

Chart calendar Organon & Co.

a2a1efba0f500d086f8dce8.VmUdYaf41G-uhEre_uLamNgFHXRhkUmd-ZJQ-CxcUGQ.b1x4DZGytzie8QGKoaPvyetVfCMuwxPlztcblUdlYQMCVCsA97SRLffHcg~e0650ef66a98cd776f390cc31bef0445

Upcoming events on Organon & Co.

2024-05-02 07:30 am Q1 2024 Earnings Release
2024-05-02 08:30 am Q1 2024 Earnings Call
2024-08-06 Q2 2024 Earnings Release (Projected)
2024-10-30 Q3 2024 Earnings Release (Projected)
2025-02-12 Q4 2024 Earnings Release (Projected)
2025-04-30 Q1 2025 Earnings Release (Projected)

Past events on Organon & Co.

2024-02-15 08:30 am Q4 2023 Earnings Call
2024-02-15 07:30 am Q4 2023 Earnings Release
2024-01-09 04:30 pm JPMorgan Healthcare Conference
2023-11-29 11:00 am Piper Sandler Healthcare Conference - Fireside Chat
2023-11-02 08:30 am Q3 2023 Earnings Call
2023-11-02 07:30 am Q3 2023 Earnings Release
2023-08-08 08:30 am Q2 2023 Earnings Call
2023-08-08 07:30 am Q2 2023 Earnings Release
2023-06-06 09:00 am Annual General Meeting
2023-05-04 08:30 am Q1 2023 Earnings Call
2023-05-04 07:30 am Q1 2023 Earnings Release
2023-02-16 08:30 am FY 2022 Earnings Call
2023-02-16 07:30 am FY 2022 Earnings Release
2023-01-10 10:30 am JP Morgan Healthcare Conference - Fireside Chat
2022-11-29 09:00 am Piper Sandler Healthcare Conference - Fireside Chat
2022-11-03 08:30 am Q3 2022 Earnings Call
2022-11-03 07:30 am Q3 2022 Earnings Release
2022-08-04 08:30 am Interim 2022 Earnings Call
2022-08-04 07:30 am Interim 2022 Earnings Release
2022-06-07 09:00 am Annual General Meeting

Past dividends on Organon & Co.

2024-02-22 Quarterly 0.28 USD
2023-11-09 Quarterly 0.28 USD
2023-08-16 Quarterly 0.28 USD
2023-05-11 Quarterly 0.28 USD
2023-02-23 Quarterly 0.28 USD
2022-11-09 Quarterly 0.28 USD
2022-08-11 Quarterly 0.28 USD
2022-05-12 Quarterly 0.28 USD
2022-02-24 Quarterly 0.28 USD
2021-11-18 Quarterly 0.28 USD

Annual results

Fiscal PeriodDecember 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		8 096


6 304
6 280
0.38%		6 174
6 186
-0.19%		6 263
6 214
0.79%
6 373

EBITDA
Million USD		Released
Forecast
Spread 		0,00


2 379
2 287
4.01%		2 085
2 104
-0.91%		1 944
1 921
1.22%
1 998

EBIT
Million USD		Released
Forecast
Spread 		0,00


2 184
2 239
-2.48%		1 873
1 971
-4.99%		1 874
1 803
3.93%
1 868

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		0,00


1 529
1 712
-10.69%		1 122
1 173
-4.35%		673
929
-27.56%
0,00

Net income
Million USD		Released
Forecast
Spread 		2 160


1 351
1 484
-8.96%		917
941
-2.55%		1 023
602
69.93%
788

EPS
USD		Released
Forecast
Spread 		0,00


5,31
5,98
-11.2%		3,59
3,71
-3.15%		3,99
2,35
69.79%
3,04

Announcement Date14/04/2117/02/2216/02/2315/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD		Released
Forecast
Spread 		1 604
1 580
1.5%		1 567
1 519
3.14%		1 585
1 532
3.49%		1 537
1 516
1.39%		1 485
1 495
-0.7%		1 538
1 538
-0.02%		1 608
1 557
3.3%		1 519
1 572
-3.39%		1 598
1 481
7.87%
1 561


1 629


1 564


1 607


1 560

EBITDA
Million USD		Released
Forecast
Spread 		549
533
2.94%		647
512
26.38%		512
474
8.1%		546
469
16.52%		380
423
-10.21%		518
535
-3.26%		530
462
14.7%		447
493
-9.4%		449
412
8.96%
451


515


515


527




EBIT
Million USD		Released
Forecast
Spread 		487
479
1.68%		594
501
18.51%		462
456
1.35%		489
446
9.54%		328
398
-17.56%		461
487
-5.3%		472
438
7.69%		430
468
-8.03%		436
405
7.67%
438


479


482


498




Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		236
419
-43.68%


287
348
-17.53%		282
256
10.16%		111
170
-34.71%		235
282
-16.67%		254
275
-7.64%		80,0
238
-66.39%		104
202
-48.51%














Net income
Million USD		Released
Forecast
Spread 		202
335
-39.7%


234
284
-17.61%		227
209
8.61%		108
139
-22.3%		177
226
-21.68%		242
220
10%		58,0
191
-69.63%		546
162
237.04%














EPS
USD		Released
Forecast
Spread 		0,79
1,11
-28.83%		1,36
0,98
38.78%		0,92
0,92
0.55%		0,89
0,82
8.54%		0,42
0,56
-25%		0,69
0,95
-27.37%		0,95
0,86
10.47%		0,23
0,74
-68.92%		2,13
0,63
238.1%














Announcement Date17/02/2205/05/2204/08/2203/11/2216/02/2304/05/2308/08/2302/11/2315/02/24-----

Upcoming sector events for Organon & Co.

2024-04-28 SHOUYAO HOLDINGS (BEIJING) CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-28 SHOUYAO HOLDINGS (BEIJING) CO., LTD.: Q4 2023 Earnings Release
2024-04-28 BEIJING AOSAIKANG PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
2024-04-28 JIANGXI FUSHINE PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
2024-04-28 AURISCO PHARMACEUTICAL CO.,LTD.: Q1 2024 Earnings Release
2024-04-28 PT TEMPO SCAN PACIFIC TBK: Q1 2024 Earnings Release (Projected)
2024-04-28 SICHUAN HUIYU PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-28 ZHEJIANG HISOAR PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
2024-04-28 ZHEJIANG HISOAR PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
2024-04-28 WEDGE INDUSTRIAL CO.,LTD.: Q1 2024 Earnings Release
More events

Past sector events for Organon & Co.

Today LUOXIN PHARMACEUTICALS GROUP STOCK CO., LTD.: Q4 2023 Earnings Release
Today NANJING VAZYME BIOTECH CO.,LTD: Q4 2023 Earnings Release
Today LUOXIN PHARMACEUTICALS GROUP STOCK CO., LTD.: Q1 2024 Earnings Release
Today HUNAN ER-KANG PHARMACEUTICAL CO., LTD: Q1 2024 Earnings Release
Today ZHUHAI RUNDU PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
Today GUIZHOU SANLI PHARMACEUTICAL CO.,LTD: Q1 2024 Earnings Release
Today GUIZHOU SANLI PHARMACEUTICAL CO.,LTD: Q4 2023 Earnings Release
Today NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL CO.,LTD.: Q1 2024 Earnings Release
Today ZHEJIANG AUSUN PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
Today ZHEJIANG AUSUN PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. OGN Stock
  4. Calendar Organon & Co.